Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
0
currently held
Exits tracked
4
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin2 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Memo Therapeutics2 periods Ysios BioFund III | Ysios Capital Partners | 2018 | 8yr | Exited 2026 | Ipsen | – | |||
Prexton Therapeutics2 periods Ysios BioFund II Innvierte | Ysios Capital Partners | 2015 | 3yr | Exited 2018 | Lundbeck | – |